Sanger Sequencing Steps: A Practical Guide for Accurate Results

Sanger sequencing remains a foundational method for DNA analysis in diagnostic laboratories, research facilities, and clinical settings. This guide covers the complete workflow from PCR amplification through capillary electrophoresis, with practical guidance for troubleshooting common problems and producing reliable sequence data. The method is still the most robust, accurate, and fast technique to sequence DNA for many applications, particularly when targeting specific genomic regions in small numbers of samples.

At a Glance

Sanger sequencing uses chain-terminating dideoxynucleotides to generate labeled fragments of different lengths that are separated by capillary electrophoresis to reveal the nucleotide sequence. The workflow requires careful attention to template quality, primer design, reaction conditions, and data interpretation.

Scope and Applications of Sanger Sequencing

Sanger sequencing is appropriate when you need accurate sequence information from a specific genomic region in a limited number of samples. The method is widely used for confirming variants identified by other methods, sequencing single genes or exons, analyzing mitochondrial DNA regions, and characterizing pathogen genomes. Published protocols demonstrate its utility for sequencing the SARS-CoV-2 S-gene to screen for variants of concern in laboratories with basic Sanger sequencing capabilities, using clinical specimens collected in nucleic acid preservation lysis-mix or virus transport medium. The approach can yield data of public health importance in a timely manner.

The method also supports diagnostic applications such as identifying polymerase epsilon (POLE) exonuclease domain mutations in endometrial cancer, where Sanger sequencing of exons 9 through 14 provides reliable identification of pathogenic variants. Similarly, Sanger sequencing is used to determine actual pathogenic variants in the SERPINA1 gene when genotyping techniques cannot provide complete identification of both alpha1-antitrypsin alleles. For viral surveillance, a simple and low-cost Sanger protocol can sequence relevant genes of the Zika virus genome, including the envelope protein and nonstructural protein 5 regions, with the resulting sequences showing 100% identity to consensus sequences from next-generation sequencing studies.

Core Principles of the Sanger Method

The Sanger sequencing method relies on DNA polymerase extending a primer annealed to a single-stranded template. The reaction mixture contains a mixture of deoxynucleotide triphosphates and fluorescently labeled dideoxynucleotide triphosphates. When a dideoxynucleotide is incorporated, chain extension stops because the molecule lacks the 3-hydroxyl group needed for phosphodiester bond formation. This produces a population of fragments that terminate at each nucleotide position along the template.

Each of the four dideoxynucleotides carries a distinct fluorescent label, allowing the instrument to identify which base terminated each fragment. Capillary electrophoresis separates the fragments by size, and a laser excites the fluorescent labels as fragments pass a detection window. The instrument records the fluorescence at each position and software converts the signal into a sequence of base calls.

The quality of the final sequence depends on the balance between deoxynucleotides and dideoxynucleotides in the reaction, the processivity of the polymerase, the purity of the template, and the efficiency of the labeling reaction. Optimized protocols adjust these parameters to produce even peak heights and long readable sequences.

PCR Amplification for Template Preparation

Primer Design Considerations

Primer design determines the specificity and efficiency of the PCR amplification that produces template for cycle sequencing. Primers should be 18 to 24 nucleotides long with a melting temperature between 55 and 65 degrees Celsius. Avoid regions of secondary structure, runs of identical nucleotides, and complementarity between primer pairs that could produce primer dimers. Check primer sequences against known polymorphisms in the target region to avoid allele dropout where a variant prevents primer annealing.

For GC-rich regions, published protocols describe optimized Sanger sequencing approaches that overcome GC content drawbacks, as demonstrated for APOE genotyping from saliva or buccal swab samples. When designing primers for formalin-fixed paraffin-embedded tissues, account for the fragmented nature of the DNA and design amplicons that are shorter than those used for high-quality DNA samples.

Amplification Reaction Setup

Set up PCR reactions in a dedicated area using separate pipettes and reagents for pre-amplification work to prevent contamination. Include a no-template control in every amplification run to detect reagent contamination. Use a hot-start polymerase to prevent mispriming during reaction setup and the initial temperature ramp.

The amplification protocol for Sanger sequencing templates typically uses 30 to 40 cycles of denaturation, annealing, and extension. The annealing temperature should be optimized for each primer pair, starting with 5 degrees Celsius below the calculated melting temperature of the primers. Verify amplification success by running an aliquot of each reaction on an agarose gel or using a quantitative method to confirm the presence of a single product of the expected size.

Template Purification

Remove unincorporated primers and nucleotides from the PCR product before cycle sequencing because these contaminants compete with the sequencing primers and reduce signal quality. Enzymatic cleanup using exonuclease I and shrimp alkaline phosphatase degrades remaining single-stranded primers and dephosphorylates unincorporated nucleotides. Alternatively, column-based purification removes primers and nucleotides while retaining the amplified product.

For formalin-fixed paraffin-embedded tissue samples, the quality of extracted DNA varies with fixation conditions and storage time. Published protocols for POLE sequencing in endometrial cancer tissues describe optimization for formalin-fixed paraffin-embedded samples, allowing reliable diagnosis according to current standards. Verify template concentration and purity after cleanup using spectrophotometry or fluorometry, and dilute the template to the concentration recommended for the sequencing chemistry in use.

Cycle Sequencing

Reaction Components

Cycle sequencing uses a thermal cycling protocol to generate labeled extension products from the purified PCR template. The reaction contains the template, a single sequencing primer, DNA polymerase, deoxynucleotides, fluorescently labeled dideoxynucleotides, and buffer components. The sequencing primer anneals to a specific site on the template and directs synthesis of the labeled fragment population.

The ratio of deoxynucleotides to dideoxynucleotides controls the average fragment length. Higher dideoxynucleotide concentrations produce shorter fragments, while lower concentrations allow longer extension before termination. Commercial sequencing chemistries are formulated to produce readable sequences of several hundred bases with even peak heights.

Thermal Cycling Parameters

Cycle sequencing uses 25 to 35 cycles of denaturation, annealing, and extension. Denaturation at 94 to 96 degrees Celsius separates the template strands. Annealing occurs at a temperature determined by the sequencing primer melting temperature, typically 50 to 60 degrees Celsius. Extension proceeds at 60 degrees Celsius, which is compatible with the modified polymerases used in cycle sequencing.

The number of cycles affects signal strength. Too few cycles produce weak signals, while too many cycles can increase background from nonspecific products. Published protocols for viral surveillance describe nested PCR approaches followed by Sanger sequencing to obtain complete envelope protein and partial NS5 sequences from Zika virus isolates, demonstrating that amplification strategy must be matched to the sample type and target region.

Primer Selection for Cycle Sequencing

The sequencing primer can be the same as one of the PCR primers or a nested primer that anneals within the amplified region. Nested primers provide additional specificity because they require a sequence match within the PCR product instead of the original template. For bidirectional sequencing, use forward and reverse primers in separate reactions to confirm the sequence from both strands.

For long amplicons, design internal sequencing primers that tile across the region of interest. Each sequencing read typically produces 400 to 900 bases of high-quality data, so multiple primers may be needed to cover larger regions. Published protocols for SERPINA1 gene sequencing describe complete gene coverage using the Sanger method to enable correct diagnosis in patients with uncommon alpha1-antitrypsin variants.

Cleanup of Sequencing Reactions

Removal of Unincorporated Dyes

After cycle sequencing, the reaction contains labeled extension products, unincorporated fluorescent dideoxynucleotides, salts, and buffer components. Unincorporated dyes must be removed because they produce a large fluorescent peak that obscures the early portion of the sequence and interferes with electrophoresis.

Ethanol precipitation removes unincorporated dyes while retaining the labeled extension products. The reaction is mixed with ethanol and a precipitation reagent, incubated to precipitate the DNA, and centrifuged to pellet the products. The supernatant containing unincorporated dyes is removed, and the pellet is washed with ethanol to remove residual salts.

Column-based cleanup uses size exclusion or ion exchange resins to retain the labeled products while allowing contaminants to pass through. This approach is faster than ethanol precipitation and produces consistent results across a range of reaction volumes. Commercial kits are available from multiple suppliers and are validated for use with specific sequencing chemistries.

Sample Preparation for Electrophoresis

After cleanup, the purified products are resuspended in a formamide solution that denatures the DNA and provides a conductive medium for electrokinetic injection. The samples are heated to denature the extension products into single strands and then cooled on ice before loading into the instrument.

Sample volume and injection conditions affect signal strength. Insufficient sample produces weak signals, while excessive salt or formamide can reduce injection efficiency. Follow the instrument manufacturer recommendations for sample preparation and storage, and include appropriate controls in each run to verify instrument performance.

Capillary Electrophoresis

Instrument Setup and Operation

Capillary electrophoresis instruments separate the labeled fragments by size as they migrate through a polymer-filled capillary under an electric field. Smaller fragments migrate faster than larger fragments, so the order of elution corresponds to increasing fragment length. A laser excites the fluorescent labels as fragments pass the detection window, and the instrument records emission at four wavelengths corresponding to the four dye labels.

Before loading samples, verify that the instrument has sufficient polymer, buffer, and anode buffer for the planned run. Check that the capillary array is free of bubbles and that the detection window is clean. Run a performance check with a standard size standard to confirm that the instrument is resolving fragments correctly and that the signal intensity is within the expected range.

Data Collection Parameters

The instrument software assigns base calls based on the fluorescence signal at each position. The software applies mobility corrections to account for differences in migration rates between fragments with different terminal dyes. Quality scores are calculated from the spacing between peaks, the signal-to-noise ratio, and the uniformity of peak heights.

Read length depends on the resolution of the separation and the quality of the sequencing reaction. Most instruments produce high-quality data for 400 to 900 bases from a single injection. The usable read length is shorter for templates with secondary structure or homopolymer regions that cause polymerase stalling or slippage.

Run Monitoring

Monitor the electrophoresis run for signs of problems. The instrument software displays the electropherogram in real time, allowing early detection of weak signals, broad peaks, or abnormal spacing. If problems are detected early in the run, the affected samples can be reinjected or the run can be stopped to prevent wasting reagents.

Published protocols for mitochondrial DNA Sanger sequencing describe developmental validation of hypervariable regions 1 and 2, demonstrating the importance of systematic validation for forensic applications where sequence accuracy is critical. Validation studies establish the performance characteristics of the method, including sensitivity, specificity, and reproducibility.

Data Analysis and Base Calling

Quality Assessment

Examine the electropherogram for each sample before accepting the sequence data. Check that the signal is strong and even across the read, that peaks are sharp and well resolved, and that the background is low. Most sequencing software assigns a quality score to each base call, and these scores should be reviewed to identify regions of low confidence.

The beginning of the read often contains artifacts from unincorporated dyes or primer peaks. The end of the read shows decreasing signal and increasing spacing between peaks as resolution declines. Trim these regions before analysis to avoid including low-quality data.

Sequence Alignment and Variant Calling

Align the processed sequence to a reference sequence to identify variants. For diagnostic applications, compare the sequence to the appropriate reference for the gene or region of interest. Published protocols for Brugada syndrome genetic testing describe reliable Sanger sequencing approaches for identifying pathogenic variants in genes associated with the condition.

When a variant is identified, confirm it by sequencing the opposite strand or by repeating the reaction from a new template preparation. This confirmation step is essential for diagnostic reporting because sequencing artifacts can produce false variant calls. For formalin-fixed paraffin-embedded samples, artifacts from DNA damage can mimic true variants, so careful review of the electropherogram is required.

Interpretation Limits

Sanger sequencing detects variants in the region covered by the sequencing primers. Variants outside the amplified region are not detected, and large deletions or insertions may be missed if they prevent primer annealing or produce fragments that are not resolved by electrophoresis. Heterozygous variants are detected as mixed peaks at the variant position, but the method is not reliably quantitative for determining the proportion of each allele.

For samples with low-level mosaicism or mixed cell populations, Sanger sequencing may not detect variants present at low frequency. Published protocols for viral surveillance note that two NS5 sequences presented ambiguities at specific positions, illustrating that some samples produce mixed signals that require careful interpretation or additional testing.

Quality Control and Validation

Controls for Each Run

Include appropriate controls in every sequencing run to verify reagent performance and instrument function. A positive control with a known sequence confirms that the entire workflow is functioning correctly. A negative control with no template detects contamination in reagents or equipment. For diagnostic applications, include a control that represents the sample type being tested, such as formalin-fixed paraffin-embedded tissue or blood.

The World Health Organization Laboratory Quality Management System Handbook provides guidance on establishing quality control procedures in diagnostic laboratories. Quality control materials should be tested with each batch of patient samples, and results should be documented to demonstrate that the method is performing within established specifications.

Method Validation

Before implementing a Sanger sequencing method for diagnostic use, validate the method to establish its performance characteristics. Validation includes determining the sensitivity, specificity, accuracy, and precision of the method. The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance describes the expectations for validation of analytical methods used in regulated applications.

Validation studies should use samples with known variants, including homozygous and heterozygous variants, to confirm that the method correctly identifies both. The studies should also assess the effect of template quality and quantity on results, particularly for challenging sample types such as formalin-fixed paraffin-embedded tissues.

Documentation and Records

Maintain complete records of sequencing runs, including the date, operator, reagents, instrument settings, and results. Records should include the raw data files, processed sequence data, and the final interpretation. The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of documentation for demonstrating the reliability of laboratory results.

For diagnostic applications, retain records for the period required by applicable regulations and accreditation standards. Records should be stored securely and be accessible for review by auditors or inspectors. Electronic records should be backed up regularly to prevent data loss.

Common Failure Patterns and Troubleshooting

Weak or Absent Signal

Weak signal in the electropherogram indicates that the sequencing reaction produced insufficient labeled products. Possible causes include insufficient template, degraded template, poor primer annealing, or inactive polymerase. Verify template concentration and quality, confirm that the primer sequence matches the template, and check that reagents are stored and handled correctly.

For formalin-fixed paraffin-embedded samples, DNA degradation during fixation and storage reduces the amount of amplifiable template. Published protocols for POLE sequencing in endometrial cancer tissues describe optimization steps that address the challenges of formalin-fixed paraffin-embedded samples, including adjustments to amplification conditions and template input.

High Background or Dirty Traces

High background fluorescence can result from incomplete removal of unincorporated dyes, contamination of reagents, or excessive template in the sequencing reaction. Repeat the cleanup step or increase the stringency of the cleanup procedure. Verify that the template was purified adequately after PCR amplification and that no-template controls show no contamination.

Mixed Signals or Ambiguous Bases

Mixed signals at specific positions can indicate a heterozygous variant, contamination with a second template, or sequencing artifacts. Compare the sequence to the reference and to the opposite strand to determine whether the mixed signal represents a true variant. If the mixed signal is not reproducible, repeat the reaction from a new template preparation.

Published protocols for Zika virus sequencing noted ambiguities at specific positions in some NS5 sequences, illustrating that mixed signals can occur even with optimized protocols. Careful review of the electropherogram and confirmation by repeat testing is required before reporting a variant.

Early Signal Drop-Off

Signal that decreases rapidly after the first 100 to 200 bases indicates that the sequencing reaction produced mostly short fragments. This can result from excessive dideoxynucleotide concentration, degraded template, or secondary structure in the template that causes polymerase stalling. Adjust the reaction conditions or redesign primers to avoid regions of secondary structure.

Failed Injections

Failed injections occur when the sample does not enter the capillary, producing no signal for that sample. Possible causes include bubbles in the sample, insufficient sample volume, or problems with the injection electrodes. Check that samples are free of bubbles, that the sample volume is adequate, and that the instrument is functioning correctly.

Safety and Regulatory Context

Laboratory Biosafety

Sanger sequencing involves handling biological samples that may contain infectious agents. The World Health Organization Laboratory Biosafety Manual provides guidance on safe handling of biological materials, including the use of appropriate containment facilities, personal protective equipment, and decontamination procedures.

Work with clinical specimens should follow the biosafety level appropriate for the sample type and the suspected pathogens. For viral surveillance applications, published protocols describe handling of clinical specimens collected in nucleic acid preservation lysis-mix or virus transport medium, which inactivate infectious agents while preserving nucleic acids for analysis.

Reagent Safety

Sequencing reagents include formamide, which is toxic, and fluorescent dyes that may be hazardous. Handle these reagents according to the safety data sheets provided by the manufacturer. Use appropriate personal protective equipment, including gloves and eye protection, when handling reagents. Dispose of waste reagents according to applicable regulations.

Regulatory Requirements

Diagnostic laboratories performing Sanger sequencing for clinical purposes must comply with applicable regulations and accreditation standards. The World Health Organization Laboratory Quality Management System Handbook describes the requirements for quality management in diagnostic laboratories, including personnel qualifications, quality control, and documentation.

The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance describes expectations for validation of analytical methods used to support regulatory submissions. Laboratories performing sequencing for clinical trials or regulatory studies should follow these guidelines to ensure that results are reliable and defensible.

Professional Escalation Criteria

When to Seek Technical Support

Contact the instrument or reagent manufacturer for technical support when troubleshooting does not resolve the problem. Document the symptoms, the steps taken to troubleshoot, and the results of each step. Provide this information to the technical support representative to facilitate diagnosis of the problem.

When to Consult a Specialist

For diagnostic applications, consult a molecular genetics specialist or clinical pathologist when results are ambiguous, when a variant cannot be confirmed, or when the result has implications for patient management. Published protocols for genetic testing describe the importance of confirming variants by multiple methods when the clinical significance is uncertain.

When to Repeat Testing

Repeat the sequencing reaction when the electropherogram quality is poor, when the sequence is incomplete, or when the result is inconsistent with clinical findings. For samples with suspected low-level variants, consider using a more sensitive method such as next-generation sequencing or allele-specific PCR to confirm the result.

Frequently Asked Questions

What is the difference between PCR amplification and cycle sequencing?

PCR amplification produces double-stranded DNA template by exponential amplification using two primers. Cycle sequencing uses a single primer and a mixture of deoxynucleotides and fluorescently labeled dideoxynucleotides to generate a population of single-stranded fragments that terminate at each nucleotide position. The labeled fragments are then separated by capillary electrophoresis to determine the sequence.

How much template DNA is needed for Sanger sequencing?

The amount of template needed depends on the sequencing chemistry and the quality of the template. Purified PCR products typically require less template than genomic DNA because the target sequence is present at higher concentration. Follow the recommendations provided by the sequencing chemistry manufacturer and verify template concentration before setting up reactions.

Why does my sequence have poor quality at the beginning?

Poor quality at the beginning of the read is commonly caused by unincorporated fluorescent dyes that were not completely removed during cleanup. The dye peak can obscure the first 20 to 50 bases of the sequence. Improve the cleanup procedure or trim the low-quality region before analysis.

How long can a Sanger sequencing read be?

Most capillary electrophoresis instruments produce high-quality data for 400 to 900 bases from a single injection. The usable read length depends on the resolution of the separation, the quality of the sequencing reaction, and the characteristics of the template. For longer regions, design multiple sequencing primers that tile across the region.

Can Sanger sequencing detect heterozygous variants?

Yes, Sanger sequencing detects heterozygous variants as mixed peaks at the variant position in the electropherogram. The height of each peak reflects the proportion of each allele in the sample. However, the method is not reliably quantitative, and low-level variants may not be detected.

What causes mixed signals in the electropherogram?

Mixed signals can result from heterozygous variants, contamination with a second template, or sequencing artifacts. Compare the sequence to the reference and to the opposite strand to determine whether the mixed signal represents a true variant. If the mixed signal is not reproducible, repeat the reaction from a new template preparation.

How do I confirm a variant identified by Sanger sequencing?

Confirm variants by sequencing the opposite strand or by repeating the reaction from a new template preparation. For diagnostic applications, use an independent method such as allele-specific PCR or next-generation sequencing to confirm clinically significant variants.

What should I do if my sequencing run fails completely?

If the entire run fails with no signal in any sample, check the instrument for mechanical problems, verify that reagents were prepared correctly, and confirm that the capillary array is functioning. Run a performance check with a standard size standard to isolate the problem to the instrument or the sequencing reactions.

Related Diagnostic Guides

• PCR Troubleshooting: No Amplification or Weak Bands
• RT-PCR Troubleshooting: No Amplification or Multiple Bands
• Agarose Gel Electrophoresis for DNA Analysis: Protocol and Troubleshooting
• DNA Ligation Troubleshooting: Common Problems and Solutions for Cloning Success
• qPCR Amplification Curve Troubleshooting: Common Shape Abnormalities and Fixes

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• A Sanger sequencing protocol for SARS-CoV-2 S-gene.. Influenza and other respiratory viruses, 2021.
• Fast and reliable Sanger POLE sequencing protocol in FFPE tissues of endometrial cancer.. Pathology, research and practice, 2023.
• Simple protocol for population (Sanger) sequencing for Zika virus genomic regions.. Memorias do Instituto Oswaldo Cruz, 2018.
• An introduction to spatial transcriptomics for biomedical research.. Genome medicine, 2022.
• CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes.. Nature protocols, 2020.
• A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications.. Genome medicine, 2017.
• Sanger and Next-Generation Sequencing of AAT.. Methods in molecular biology (Clifton, N.J.), 2024.
• Data quality control in genetic case-control association studies.. Nature protocols, 2010.
• Protocol for total RNA sequencing analysis of extracellular RNA from biofluids.. 2026.
• STARCall integrates image stitching, alignment, and read calling to enable scalable analysis of in situ sequencing data.. 2026.
• From Bench to Insight: Rapid Pathogen Genomic Surveillance Workflow for SARS-CoV-2 and Emerging Pathogens. 2026.
• Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing data.. 2026.
• Phylogenetic and Genomic Characterization of Whole Genome Sequences of a Herpes Simplex Virus Type 1 Isolate Identified Genomic Variant Characteristics in a Human Subject with Fulminant Hepatitis.. 2026.
• APOE Variants in an Iberian Alzheimer Cohort Detected through an Optimized Sanger Sequencing Protocol. Genes, 2020.
• Author response for "A Sanger sequencing protocol for SARS-CoV-2 S-gene". 2021.
• Sanger sequencing protocol - BRCA1/2 mutations are not a common cause of malignant melanoma in the Polishpopulation v1. protocols.io, 2018.
• Brugada syndrome genetic testing: A reliable sanger sequencing protocol. 2015.
• Developmental validation for Sanger sequencing of HV1 and HV2 in mitochondrial DNA. Forensic Science International Reports, 2020.
• Sanger Sequencing of Lyssaviruses. Current Laboratory Techniques in Rabies Diagnosis Research and Prevention, 2014.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.